Digital Measurements and Endpoints on Hybrid and Conventional Trials CHI’s 7th Digital Measurements program will feature clinical trial case studies that employ the use of sensors and wearables. The program will also discuss the future steps needed for implementation of digital biomarkers and endpoints in clinical trials. Topics to be explored are digital biomarkers (examples and validations, NDE (outcomes and assessments), evolving regulations, and digital measurements as a key enabler for decentralized trials. The stream includes two unique parts, each of which features its own set of topics and speakers.